August 2021

Scientists from the USC Stem Cell laboratory of Neil Segil have identified a natural barrier to the regeneration of the inner ear’s sensory cells, which are lost in hearing and balance disorders. Overcoming this barrier may be a first step in returning inner ear cells to a newborn-like state that’s primed for regeneration, as described in a new study published in Developmental Cell.

Takeda Pharmaceutical Company Limited and Frazier Healthcare Partners (Frazier) announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical company to develop and commercialize Takedas norovirus vaccine candidate. Takeda has granted a license to HilleVax for the exclusive development and commercialization rights to its norovirus vaccine candidate, HIL-214 (formerly TAK-214), worldwide outside of Japan, in exchange for upfront consideration, as well as future cash milestones and royalties on net sales.

Under the jurisdiction of District Urban Health Unit, Vadodara, District Panchayat, advertisements are made to fill the vacancies in various Urban Health Centers with one month contract based fixed salary. Vacancies are fixed pay contractual basis.  This program can be canceled after completion.  There are no fixed types of dividends or other financial benefits.

Post : Pharmacist (GUHP)

In the interest of the public due to the Corona virus (COVID - 19) epidemic, the staff of the Government Medical College Hospital will be selected and appointed to the Corona treatment units on a contract basis for a specified number of less than six months.

Post : Pharmacist

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.

Post: Officer / Executive - QA / IPQA, Solid Orals and Injectables

National Vrkshayuuveda Research Institute Jhansi established in the year 1973, renamed as Central Ayurveda Research Institute in Dec 2020, is engaged in the research with the focus mandate, conduct medicio-botanical exploration in parts of Central India ii. Collect and supply genuine raw drug materials for R&D work To build up repositories for medicinal plants and crude drugs. To established herbal garden and carrying out cultivation of medicinal plants for Ayurveda.

In compliance with the instructions given by the Mission Operator, National Health Mission, Raipur under National Health Mission in Raigad district, letter number / NHM / HR / 2020 / NS - 1596 / 1635 Nava Raipur, Atal Nagar, dated 30/12/2020  , R.O.P.  District reservation roster by conducting skill test / written test / interview by inviting applications through walk-in-interview on the vacant contract posts shown in the following table for contract appointment against the new and vacant posts approved in the financial year 2021-22.